TNF and inflammatory bowel disease: Anti‐inflammatory agents, including TNFα and anti‐α4β7 integrin antagonists, effectively restored optimal IR‐TCF7high expression in inflammatory bowel disease patients who exhibited a MAS‐1high profile at baseline (Figure 9c and Figure S48).